Healthcare Business - Page 2

Could Sage Therapeutics’ Depression Drug Be the Next Big Thing?

Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from ...
Read Full Story »

Arrowhead Pharma Wins in Midstage Hepatitis Study

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) saw its shares make a handy gain early Wednesday after the firm presented new data from its midstage study for the treatment of hepatitis B ...
Read Full Story »

How a Key Health Care Merger May Play a Role in Warren Buffett’s Investing

There has been a stealthy, big merger in health care that has now been announced, and despite the consolidation it seems to be too small for regulators to challenge. This ...
Read Full Story »

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

With 2017 coming to an end, investors are wondering how they should be investing for 2018 and beyond. At the start of December, the Dow was up just over 20% ...
Read Full Story »

Quanterix Gears Up for IPO

Quanterix has registered an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering. The company intends to price its 3.34 million shares in ...
Read Full Story »

Revance Scores Solid Results in Late-Stage Trial

Shares of Revance Therapeutics Inc. (NASDAQ: RVNC) saw a solid gain early on Tuesday after the company announced positive top-line results from its late-stage trials. Specifically, the firm’s next-generation neuromodulator ...
Read Full Story »

Jefferies Has 4 Red-Hot Biotech Stock Picks for December

Barring a huge meltdown, the S&P 500 will once again have a double-digit year of gains, and most investors should be looking at their 401(k)s and other accounts with some ...
Read Full Story »

Why Apple Is Propping Up BioTelemetry

BioTelemetry Inc. (NASDAQ: BEAT) shares saw a handy gain on Thursday after a new partnership with Apple Inc. (NASDAQ: AAPL) was announced. Specifically, these companies are joining forces to provide ...
Read Full Story »

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

With the market looking ready to continue running to all-time highs despite yesterday's selling, many pundits feel this late stage part of the rally is more people trying to get ...
Read Full Story »

Apollo Endosurgery Surges on FDA Approval

Shares of Apollo Endosurgery Inc. (NASDAQ: APEN) saw a healthy gain early on Tuesday after the company announced it had received 510k clearance from the U.S. Food and Drug Administration ...
Read Full Story »

Quanterix Closes in on IPO

Quanterix has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering (IPO). The company intends to price its 3.34 ...
Read Full Story »

Will Teva’s Restructuring Stop the Bleeding?

Shares of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) rose Monday after the company announced a reorganization some of its top leadership positions. This stock has been brutalized in 2017, and ...
Read Full Story »

Odonate Therapeutics Gears Up for IPO

Odonate Therapeutics registered an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). The company expects to price its 5.88 million shares ...
Read Full Story »

NVIDIA, GE Healthcare Strike Deal on AI

Artificial intelligence (AI) has been the next big thing for over a year now, and there are still new worlds to conquer for AI software and hardware. Industry leader NVIDIA ...
Read Full Story »

Alkermes Could Win Big With New Biogen Partnership

Alkermes PLC (NASDAQ: ALKS) shares made a handy gain to start the week, after the firm announced that it has entered into a global license agreement with Biogen Inc. (NASDAQ: ...
Read Full Story »